Covid-19 coronavirus: Canberra has ordered 84m doses of now paused trial vaccine

New Zealand Herald

Published

The Covid-19 vaccine Australia has invested in has been dealt a major setback after researchers uncovered a suspected serious adverse reaction in a trial participant.The vaccine, being developed by pharmaceutical giant AstraZeneca...

Full Article